Lacaba, Jennifer L.

HRN: 25-35-19  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/27/2024
07/04/2024
IVTT
2.25
Q6H
Cholangitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: